Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$31.23 - $42.99 $118,986 - $163,791
3,810 New
3,810 $128,000
Q3 2023

Nov 09, 2023

BUY
$25.44 - $37.35 $196,167 - $288,005
7,711 Added 15.58%
57,205 $1.46 Million
Q2 2023

Aug 09, 2023

BUY
$23.94 - $32.36 $126,618 - $171,152
5,289 Added 11.96%
49,494 $1.42 Million
Q1 2023

May 12, 2023

BUY
$14.72 - $23.97 $118,996 - $193,773
8,084 Added 22.38%
44,205 $1.06 Million
Q4 2022

Feb 09, 2023

BUY
$14.14 - $23.06 $109,429 - $178,461
7,739 Added 27.27%
36,121 $612,000
Q3 2022

Nov 09, 2022

SELL
$13.05 - $22.13 $40,637 - $68,912
-3,114 Reduced 9.89%
28,382 $421,000
Q2 2022

Aug 11, 2022

BUY
$12.26 - $31.17 $386,140 - $981,730
31,496 New
31,496 $496,000
Q1 2022

May 12, 2022

SELL
$17.64 - $39.57 $353,840 - $793,734
-20,059 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$34.2 - $47.56 $686,017 - $954,006
20,059 New
20,059 $742,000
Q3 2021

Nov 12, 2021

SELL
$27.88 - $58.25 $216,181 - $451,670
-7,754 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$25.79 - $42.11 $475,877 - $777,013
-18,452 Reduced 70.41%
7,754 $262,000
Q1 2021

May 12, 2021

BUY
$38.75 - $86.92 $350,958 - $787,234
9,057 Added 52.81%
26,206 $1.08 Million
Q4 2020

Feb 10, 2021

SELL
$34.61 - $123.66 $125,045 - $446,783
-3,613 Reduced 17.4%
17,149 $744,000
Q3 2020

Nov 12, 2020

BUY
$37.49 - $63.19 $92,375 - $155,700
2,464 Added 13.47%
20,762 $891,000
Q2 2020

Aug 13, 2020

SELL
$12.66 - $58.27 $8,191 - $37,700
-647 Reduced 3.42%
18,298 $855,000
Q1 2020

May 13, 2020

SELL
$9.31 - $18.26 $114,876 - $225,310
-12,339 Reduced 39.44%
18,945 $257,000
Q4 2019

Feb 10, 2020

BUY
$8.93 - $12.41 $147,737 - $205,311
16,544 Added 112.24%
31,284 $340,000
Q3 2019

Nov 12, 2019

BUY
$8.8 - $14.5 $128,444 - $211,642
14,596 Added 10136.11%
14,740 $151,000
Q2 2019

Aug 09, 2019

BUY
$5.78 - $9.79 $832 - $1,409
144 New
144 $1,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $451M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.